Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 108
Filter
1.
J Neural Eng ; 20(1)2023 01 20.
Article in English | MEDLINE | ID: mdl-36603218

ABSTRACT

Objective:The main objective of this study was to induce and evaluate drug-dose-dependent outer retinal degeneration in cynomolgus monkeys by application of N-methyl-N-nitrosourea (MNU).Approach:Intravitreal temporary tamponade induced outer retinal degeneration with MNU solutions (2-3 mg ml-1) after vitrectomy in five cynomolgus monkeys. Optical coherence tomography (OCT), fundus autofluorescence (FAF), full-field electroretinography (ffERG), and visual evoked potentials (VEP) were performed at baseline and weeks 2, 6, and 12 postoperatively. At week 12, OCT angiography, histology, and immunohistochemistry were performed.Main results:Outer retinal degeneration was observed in four monkeys, especially in the peripheral retina. Anatomical and functional changes occurred at week 2 and persisted until week 12. FAF images showed hypoautofluorescence dots, similar to AF patterns seen in human retinitis pigmentosa. Hyperautofluorescent lesions in the pericentral area were also observed, which corresponded to the loss of the ellipsoid zone on OCT images. OCT revealed thinning of the outer retinal layer adding to the loss of the ellipsoid zone outside the vascular arcade. Histological findings confirmed that the abovementioned changes resulted from a gradual loss of photoreceptors from the perifovea to the peripheral retina. In contrast, the inner retina, including ganglion cell layers, was preserved. Functionally, a decrease or extinction of scotopic ffERGs was observed, which indicated rod-dominant loss. Nevertheless, VEPs were relatively preserved.Significance:Therefore, we can conclude that temporary exposure to intravitreal MNU tamponade after vitrectomy induces rod-dominant outer retinal degeneration in cynomolgus monkeys, especially in the peripheral retina.


Subject(s)
Retinal Degeneration , Animals , Macaca fascicularis , Methylnitrosourea/adverse effects , Evoked Potentials, Visual , Retina/pathology , Primates , Tomography, Optical Coherence/methods
2.
STAR Protoc ; 2(4): 100814, 2021 12 17.
Article in English | MEDLINE | ID: mdl-34585155

ABSTRACT

N-Methyl-N-nitrosourea, an N-nitroso compound converted from dietary nitrite by Helicobacter pylori, causes somatic mutations in epithelial cells and induces gastric premalignancy. Here, we describe a detailed protocol for induction of gastric tumor and analysis of tumor phenotypes in mice. This model can be widely used for studying the initiation and growth of gastric cancer. For complete details on the use and execution of this protocol, please refer to Li et al. (2021).


Subject(s)
Methylnitrosourea/adverse effects , Neoplasms, Experimental , Stomach Neoplasms , Animals , Male , Mice , Mice, Inbred C57BL , Stomach/drug effects , Stomach/pathology
3.
Sci Rep ; 11(1): 12616, 2021 06 16.
Article in English | MEDLINE | ID: mdl-34135387

ABSTRACT

This study aimed to investigate the impact of chronic low-level exposure to chemical carcinogens with different modes of action on the cellular response to ionising radiation. Human lymphoblastoid GM1899A cells were cultured in the presence of 4-nitroquinoline N-oxide (4NQO), N-nitroso-N-methylurea (MNU) and hydrogen peroxide (H2O2) for up to 6 months at the highest non-(geno)toxic concentration identified in pilot experiments. Acute challenge doses of 1 Gy X-rays were given and chromosome damage (dicentrics, acentric fragments, micronuclei, chromatid gaps/breaks) was scored. Chronic exposure to 20 ng/ml 4NQO, 0.25 µg/ml MNU or 10 µM H2O2 hardly induced dicentrics and did not significantly alter the yield of X-ray-induced dicentrics. Significant levels of acentric fragments were induced by all chemicals, which did not change during long-term exposure. Fragment data in combined treatment samples compared to single treatments were consistent with an additive effect of chemical and radiation exposure. Low level exposure to 4NQO induced micronuclei, the yields of which did not change throughout the 6 month exposure period. As for fragments, micronuclei yields for combined treatments were consistent with an additive effect of chemical and radiation. These results suggest that cellular radiation responses are not affected by long-term low-level chemical exposure.


Subject(s)
4-Nitroquinoline-1-oxide/adverse effects , Chromosomes/genetics , Hydrogen Peroxide/adverse effects , Lymphocytes/cytology , Methylnitrosourea/adverse effects , Cell Line , Cell Survival/drug effects , Cell Survival/radiation effects , Chromosomes/drug effects , Chromosomes/radiation effects , Humans , Lymphocytes/drug effects , Lymphocytes/radiation effects , Micronucleus Tests , Radiation Dosage , Radiation Tolerance , Time Factors
4.
Am J Chin Med ; 47(8): 1885-1899, 2019.
Article in English | MEDLINE | ID: mdl-31838869

ABSTRACT

Diet polyphenol can reportedly prevent the formation of breast-cancer cells. Nelumbo nucifera leaf extract (NLE) is enriched with polyphenols and has several cellular functions, such as anti-atherosclerosis, anti-inflammation, and antitumor. In this study, we investigated the role of NLE in the prevention of N-methyl-N-nitrosourea (NMU)-induced mammary tumor formation. Cotreatment with NLE significantly reduced the NMU-induced tumor incidence, number, and volume. NLE administration significantly repressed the tumor growth and weight of nude mice upon inoculation with BT-474 cancer cells. Immunohistochemical staining indicated that fatty acid synthetase, estrogen receptor (ER)-α, and phosphorylated ER-α were obviously reduced in the cancer part of BT-474 inoculated nude mice upon administration of 2% NLE. Western blot analysis revealed that NLE and NLPE (polyphenol-rich NLE) repressed ER-α expression and phosphorylation and decreased the phosphorylation of Her-2 without affecting their expression. Overall, NLE and NLPE exhibited more effective antitumor abilities in NMU-induced mammary cancer formation than with tamoxifen and Herceptin.


Subject(s)
Breast Neoplasms/drug therapy , Drugs, Chinese Herbal/administration & dosage , Estrogen Receptor alpha/metabolism , Fatty Acid Synthases/genetics , Nelumbo/chemistry , Receptor, ErbB-2/genetics , Animals , Breast Neoplasms/chemically induced , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Down-Regulation/drug effects , Estrogen Receptor alpha/genetics , Fatty Acid Synthases/metabolism , Female , Humans , Methylnitrosourea/adverse effects , Mice , Mice, Nude , Rats , Rats, Sprague-Dawley , Receptor, ErbB-2/metabolism
5.
BMC Cancer ; 19(1): 996, 2019 Oct 24.
Article in English | MEDLINE | ID: mdl-31651285

ABSTRACT

BACKGROUND: This study evaluates the anti-cancer effects of Tadalafil (potent PDE-5 inhibitor) in female albino wistar rats against n-methyl n-nitrosourea induced mammary gland carcinogenesis. METHODS: The animals were selected and randomly divided among four groups and each group contains six animals per group. The animal tissue and serum samples were evaluated for the presence of antioxidant parameters and the cellular morphology was studied using carminic staining, haematoxylin staining and scanning electron microscopy followed by immunoblotting analysis. RESULTS: On the grounds of hemodynamic recordings and morphology, n-methyl n-nitrosourea treated group showed distorted changes along with distorted morphological parameters. For morphological analysis, the mammary gland tissues were evaluated using scanning electron microscopy, whole mount carmine staining, haematoxylin and eosin staining. The serum samples were evaluated for the evaluation of oxidative stress markers and inflammatory markers. The level of caspase 3 and 8 were also evaluated for the estimation of apoptosis. The fatty acid profiling of mammary gland tissue was evaluated using fatty acid methyl esters formation. The mitochondrial mediated apoptosis and inflammatory markers were evaluated using immunoblotting assay. CONCLUSION: The results confirm that Tadalafil treatment restored all the biological markers to the normal and its involvement in mitochondrial mediated death apoptosis pathway along with inhibition of inflammatory markers.


Subject(s)
Lipoxygenase/metabolism , Mammary Neoplasms, Experimental/prevention & control , Mitochondria/drug effects , Oxidative Stress/drug effects , Phosphodiesterase 5 Inhibitors/therapeutic use , Prostaglandin-Endoperoxide Synthases/metabolism , Signal Transduction/drug effects , Tadalafil/therapeutic use , Animals , Apoptosis/drug effects , Carcinogenesis/metabolism , Caspase 3/metabolism , Caspase 8/metabolism , Female , Heart Rate/drug effects , Inflammation Mediators/blood , Mammary Neoplasms, Experimental/chemically induced , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/pathology , Methylnitrosourea/adverse effects , Methylnitrosourea/pharmacology , Mitochondria/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
6.
Drug Des Devel Ther ; 13: 2689-2702, 2019.
Article in English | MEDLINE | ID: mdl-31496648

ABSTRACT

OBJECTIVE: Retinitis pigmentosa causes progressive photoreceptor degeneration in the subjects while no clinical therapy exists. The present study sought to evaluate the potential protective effects of taurine on a pharmacologically induced RP animal model. METHODS: Photoreceptor degeneration in mice was induced by an intraperitoneal injection of N-methyl-N-nitrosourea (MNU). The MNU-administrated mouse received taurine treatment and then they were examined by electroretinography, spectral-domain optical coherence tomography, optokinetic test, and histological and immunohistochemistry assay. RESULTS: Prominent taurine deficiency was found in the retinas of MNU-administered mice. Intravenous taurine treatment increased significantly the retinal taurine level. Morphological studies showed that taurine could alleviate the retinal disorganizations in the MNU-induced mice. Taurine also ameliorated the visual impairments in the MNU-induced mice as evidenced by functional examinations. Immunostaining experiments demonstrated that both the M-cone and S-cone populations in the degenerative retinas are rescued by taurine. In particular, the M-cone photoreceptors in superior-temporal quadrant and the S-cone photoreceptors in inferior-nasal quadrant were preferentially rescued. Mechanism study showed that the photoreceptor apoptosis and oxidative stress in the degenerative retina were effectively alleviated by taurine treatment. CONCLUSION: Taurine is protective against the MNU-induced photoreceptor degeneration. Systemic taurine administration may act as a promising therapeutic potion for retinopathies with chronic cycle.


Subject(s)
Photoreceptor Cells, Vertebrate/drug effects , Retinal Degeneration/drug therapy , Taurine/pharmacology , Vision Disorders/drug therapy , Animals , Apoptosis/drug effects , Disease Models, Animal , Female , Injections, Intraperitoneal , Injections, Intravenous , Male , Methylnitrosourea/administration & dosage , Methylnitrosourea/adverse effects , Methylnitrosourea/pharmacology , Mice , Mice, Inbred C57BL , Neuroprotective Agents/administration & dosage , Photoreceptor Cells, Vertebrate/metabolism , Photoreceptor Cells, Vertebrate/pathology , Retinal Degeneration/metabolism , Retinal Degeneration/pathology , Taurine/administration & dosage , Tomography, Optical Coherence , Vision Disorders/metabolism , Vision Disorders/pathology
7.
J Toxicol Sci ; 44(4): 273-282, 2019.
Article in English | MEDLINE | ID: mdl-30944280

ABSTRACT

Previously, we reported that the frequency of micronucleated reticulocytes (MNRETs) in the peripheral blood of male C3H/He mice intraperitoneally administered ethylnitrosourea (ENU) (25 mg/kg body weight) in the dark period (zeitgeber time, ZT15) was higher than in the light period (ZT3). In this study, to clarify the mechanism underlying this phenomenon, we investigated the differences in micronucleus (MN) induction observed between ZT3 and ZT15 using five chemicals, methylnitrosourea (MNU), ethylmethane sulfonate (EMS), mitomycin C, cyclophosphamide and vincristin. MNU and EMS, monofunctional alkylating agents, showed higher frequencies of MNRETs in the ZT15 than the ZT3 treatment similar to ENU. However, no differences were observed for the other chemicals. In the comet assay, more DNA damage was induced by ENU in the ZT15 than the ZT3 treatment. Furthermore, the plasma erythropoietin (EPO) level, a known effector of MN induction with anti-apoptotic activity mediated by Bcl-xL expression, was higher in the dark than in the light period. EPO did not increase the frequency of MNRETs. However, in the ENU treatment group at ZT3 following EPO injection a significant increase of MNRETs was observed similar to the ZT15 treatment. Higher expression of apoptosis-related genes such as Bcl-xL was induced in bone marrow cells from mice treated with ENU at ZT15 compared with ZT3. From these results, it was speculated that the differences in MN induction in the peripheral blood of mice exposed to monofunctional alkylating agents such as ENU depend on apoptotic or anti-apoptotic conditions related to the circadian rhythms of EPO in bone marrow.


Subject(s)
Administration, Metronomic , Alkylating Agents/administration & dosage , Alkylating Agents/adverse effects , Cell Nucleolus/drug effects , Cell Nucleolus/pathology , Circadian Rhythm/physiology , Cyclophosphamide/administration & dosage , Cyclophosphamide/pharmacology , Erythropoietin/physiology , Ethyl Methanesulfonate/pharmacology , Methylnitrosourea/administration & dosage , Methylnitrosourea/adverse effects , Mitomycin/administration & dosage , Mitomycin/adverse effects , Reticulocytes/cytology , Reticulocytes/drug effects , Vincristine/administration & dosage , Vincristine/adverse effects , Animals , Apoptosis/drug effects , Apoptosis/genetics , Bone Marrow Cells/drug effects , Bone Marrow Cells/pathology , Cell Nucleolus/genetics , DNA Damage/drug effects , Darkness , Erythropoietin/metabolism , Erythropoietin/pharmacology , Ethyl Methanesulfonate/administration & dosage , Light , Male , Mice, Inbred C3H , Time , bcl-X Protein/metabolism
8.
Anticancer Res ; 38(11): 6317-6320, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30396952

ABSTRACT

BACKGROUND/AIM: The evolution of gastric carcinogenesis remains largely unknown, as the regulatory mechanisms involved in the aggressiveness of gastric cancer are still poorly understood. Kinases are downstream modulators and effectors of various cell signaling cascades and play key roles in the development of neoplastic diseases. The objective of this study was to evaluate the expression of genes and proteins of the SRC family, including FYN, YES, BLK, FGR, LYN and SRC, in a model of intestinal gastric carcinogenesis generated by treating Cebus apella, a New World non-human primate, with N-methyl nitrosourea (MNU). MATERIALS AND METHODS: mRNA expression of genes was measured by real-time reverse transcription quantitative PCR (RT-qPCR) and protein expression was measured by western blotting in six Cebus apella treated with N-methyl-nitrosourea (MNU) for about 2.5 years. RESULTS: Elevated mRNA and protein expression mainly of the SRC and LYN kinases was observed. Their expression was gradually increasing as non-atrophic gastritis was evolving to gastric cancer. CONCLUSION: SRC family kinases play a key role in tumor progression and metastasis and may be a promising target for the treatment of gastric cancer.


Subject(s)
Methylnitrosourea/adverse effects , Stomach Neoplasms/metabolism , src-Family Kinases/genetics , src-Family Kinases/metabolism , Animals , Cebus , Disease Models, Animal , Disease Progression , Gene Expression Regulation, Neoplastic , Neoplasm Metastasis , Stomach Neoplasms/chemically induced , Stomach Neoplasms/genetics , Up-Regulation
9.
Cancer Sci ; 109(5): 1480-1492, 2018 May.
Article in English | MEDLINE | ID: mdl-29532565

ABSTRACT

Previously no mouse gastric cancer cell lines have been available for transplantation into C57BL/6 mice. However, a gastric cancer model in immunocompetent mice would be useful for analyzing putative therapies. N-Methyl-N-nitrosourea (MNU) was given in drinking water to C57BL/6 mice and p53 heterozygous knockout mice. Only 1 tumor from a p53 knockout mouse could be cultured and the cells s.c. transplanted into a C57BL/6 mouse. We cultured this s.c. tumor, and subcloned it. mRNA expression in the most aggressive YTN16 subline was compared to the less aggressive YTN2 subline by microarray analysis, and fibroblast growth factor receptor 4 (FGFR4) in YTN16 cells was knocked out with a CRISPR/Cas9 system and inhibited by an FGFR4 selective inhibitor, BLU9931. These transplanted cell lines formed s.c. tumors in C57BL/6 mice. Four cell lines (YTN2, YTN3, YTN5, YTN16) were subcloned and established. Their in vitro growth rates were similar. However, s.c. tumor establishment rates, metastatic rates, and peritoneal dissemination rates of YTN2 and YTN3 were lower than for YTN5 and YTN16. YTN16 established 8/8 s.c. tumors, 7/8 with lung metastases, 3/8 with lymph node metastases and 5/5 with peritoneal dissemination. FGFR4 expression by YTN16 was 121-fold higher than YTN2. FGFR4-deleted YTN16 cells failed to form s.c. tumors and showed lower rates of peritoneal dissemination. BLU9931 significantly inhibited the growth of peritoneal dissemination of YTN16. These studies present the first transplantable mouse gastric cancer lines. Our results further indicate that FGFR4 is an important growth signal receptor in gastric cancer cells with high FGFR4 expression.


Subject(s)
Cell Line, Tumor/cytology , Methylnitrosourea/adverse effects , Receptor, Fibroblast Growth Factor, Type 4/metabolism , Stomach Neoplasms/pathology , Tumor Suppressor Protein p53/genetics , Animals , Cell Proliferation , Gene Knockout Techniques , Immunocompetence , Mice , Mice, Inbred C57BL , Mice, Knockout , Neoplasm Metastasis , Neoplasm Transplantation , Stomach Neoplasms/chemically induced , Stomach Neoplasms/metabolism
10.
In Vivo ; 32(2): 249-254, 2018.
Article in English | MEDLINE | ID: mdl-29475906

ABSTRACT

BACKGROUND/AIM: Physical exercise is increasingly considered by many authors to be a factor reducing the risk of cancer development and premature cancer-related death. Data indicate higher cure rates and longer times of survival in cancer patients who regularly exercise. MATERIALS AND METHODS: A total of 50 female Sprague-Dawley rats were used in the experiment. Animals at 1 month of age were intraperitoneally injected with N-methyl-N-nitrosourea. Three months following drug administration, rats underwent supervised physical training. The animals were divided into four groups: control untrained group and 3 groups trained with different intensities - i.e. low, moderate and high. Routine histopathological examination of tumors was performed and mitotic activity was assessed by immunohistochemical expression of the Ki-67 antigen. RESULTS: Ki-67 antigen expression was observed in all analyzed tumors. The increase in Ki-67 antigen expression correlated positively with the increase in training intensity. CONCLUSION: It can be assumed that low-intensity physical training is safe for patients with breast cancer. However, moderate- and high-intensity training may induce tumor cell proliferation worsening patients' prognosis.


Subject(s)
Breast Neoplasms/etiology , Exercise , Physical Conditioning, Animal , Animals , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Breast Neoplasms/prevention & control , Cell Transformation, Neoplastic/chemically induced , Disease Models, Animal , Female , Humans , Immunohistochemistry , Methylnitrosourea/administration & dosage , Methylnitrosourea/adverse effects , Rats
11.
Brain Res ; 1678: 47-55, 2018 Jan 01.
Article in English | MEDLINE | ID: mdl-29038003

ABSTRACT

Retina is a critical component of the central nerve system that is responsible for the conversion of light stimulus into electrical spikes. Retinitis pigmentosa (RP) comprises a heterogeneous group of inherited retinal dystrophies leading to blindness. We examined retinal neuroglobin (Ngb) expression in a pharmacologically induced RP animal model, the N-Methyl-N-nitrosourea (MNU) administered mice. The retinal Ngb expression in MNU administered mice attenuated following a time dependent manner, suggesting Ngb was involved in the photoreceptor degeneration. Conversely, the intravenous delivery of Hemin, a Ngb up-regulator, enhanced the Ngb expressions in the retinas of MNU administered mice. Optokinetic behavioral tests and Electroretinogram (ERG) examination suggested that the Hemin treatment could improve the visual function of MNU administered mice. The retinal morphology of the Hemin treated group was much more intact than the MNU group as evidenced by retinal sections and optical coherence tomography (OCT) examinations. Moreover, immunostaining experiments showed the cone photoreceptors in the MNU administered mice were also rescued by Hemin treatment. Furthermore, mechanism studies suggested the Hemin treatment not only alleviated the oxidative stress, but also rectified the apoptotic changes in the retinas of MNU administered mice. In conclusion, the intraperitoneally delivery of Hemin can enhance the Ngb expressions in the MNU administered retinas, thereby ameliorating the photoreceptor degeneration and associated visual impairments. These findings would shed light on the opportunity to develop Ngb into a therapeutic molecular against RP.


Subject(s)
Globins/metabolism , Nerve Tissue Proteins/metabolism , Photoreceptor Cells/drug effects , Retinal Degeneration/prevention & control , Animals , Disease Models, Animal , Electroretinography/methods , Globins/drug effects , Hemin/metabolism , Methylnitrosourea/adverse effects , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/drug effects , Neuroglobin , Oxidative Stress , Photoreceptor Cells/metabolism , Photoreceptor Cells, Vertebrate/metabolism , Retina/metabolism , Retinal Degeneration/physiopathology
12.
Clin Genitourin Cancer ; 16(3): e587-e593, 2018 06.
Article in English | MEDLINE | ID: mdl-29174504

ABSTRACT

BACKGROUND: The Toll-like receptor (TLR)2/4 agonist bacillus Calmette-Guérin (BCG), although not failure proof, has been the most efficient immunomodulatory treatment of immunogenic nonmuscle-invasive bladder cancer (NMIBC) for > 40 years. We investigated the role of the immunomodulatory molecule TLR7 agonist imiquimod through the BCG key receptors TLR2/4 and the main downstream molecules of the mammalian target of rapamycin pathway in NMIBC treatment. MATERIALS AND METHODS: A total of 40 Fischer-344 rats, 7 weeks old, received 4 doses of 1.5 mg/kg N-methyl-N-nitrosourea intravesically on weeks 0, 2, 4, and 6 for cancer induction. At week 8, the rats were randomized into 4 groups (10 per group) and treated intravesically once a week for 6 weeks: control (0.2 mL of vehicle); BCG (2 × 106 colony-forming units Connaught strain in 0.2 mL); imiquimod (20 mg/kg in 0.2 mL), and associated treatment BCG plus imiquimod in 0.2 mL. The bladders were extracted and analyzed for histopathology, immunohistochemistry, cell proliferation (Ki-67), apoptosis (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling [TUNEL]), and immunoblotting for TLR2, TLR4, p-P70S6K, and p-4E-BP1 proteins. RESULTS: The histopathology results showed that BCG and imiquimod decreased bladder tumorigenesis compared with the control group, with a proliferation decrease (Ki-67) and an apoptosis increase (TUNEL). BCG upregulated TLR2/4, imiquimod upregulated TLR4, and both downregulated P70S6K1. CONCLUSION: Imiquimod is able to efficiently decrease bladder carcinogenesis through upregulation of TLR7/4 and downregulation of P70S6K1 protein, generating new perspectives to boost BCG effects in the future.


Subject(s)
Adjuvants, Immunologic/administration & dosage , BCG Vaccine/administration & dosage , Imiquimod/administration & dosage , Methylnitrosourea/adverse effects , Urinary Bladder Neoplasms/drug therapy , Adjuvants, Immunologic/pharmacology , Administration, Intravesical , Animals , BCG Vaccine/pharmacology , Cell Proliferation/drug effects , Drug Synergism , Female , Gene Expression Regulation, Neoplastic/drug effects , Imiquimod/pharmacology , Random Allocation , Rats , Rats, Inbred F344 , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Treatment Outcome , Urinary Bladder Neoplasms/chemically induced , Xenograft Model Antitumor Assays
13.
Curr Mol Med ; 17(2): 100-107, 2017.
Article in English | MEDLINE | ID: mdl-28429669

ABSTRACT

Animal models with pharmacologically induced retinal degeneration including sodium iodate (NaIO3) and N-methyl-N-nitrosourea (MNU) have been extensively used in ophthalmic research to investigate retinal degeneration. NaIO3 induces degeneration of the retinal pigment epithelium (RPE) followed by photoreceptor (PRC) cell death, mimicking features of age-related macular degeneration. In contrast, MNU leads to rapid destruction of the PRCs only, enabling the use of the MNU model to investigate degeneration induced in retinitis pigmentosa. It has been shown that multiple cell death pathways are involved in the cell-specific effects of the toxins. Necrosis has been identified as the cause of the NaIO3-induced RPE loss. PRC degeneration in the described models is mainly induced by programmed cell death, indicated by the upregulation of conventional apoptosis initiator and effector caspases. However, recent research points to the additional involvement of caspase-independent processes as endoplasmic reticulum stress and calpain activation. Since there is still a substantial amount of contradictory hypotheses concerning triggers of cell death, the use of pharmacological models is controversial. Thereby, the advantages of such models like the application reaching across species and strains as well as modulation of onset and severity of damage are not exploited to a full extent. Thus, the present review aims to give more insight into the involved cell death pathways and discusses recent findings in the most widely used retinal degeneration models. It might facilitate further studies aiming to develop putative therapeutic approaches for retinal degenerative diseases including combinatory treatment with cell death inhibitors and cell transplantation therapy.


Subject(s)
Disease Models, Animal , Drug-Related Side Effects and Adverse Reactions , Pharmaceutical Preparations , Retinal Degeneration/etiology , Animals , Anti-Bacterial Agents/adverse effects , Humans , Iodates/adverse effects , Iodoacetic Acid/adverse effects , Methylnitrosourea/adverse effects , Photoreceptor Cells, Vertebrate/drug effects , Photoreceptor Cells, Vertebrate/metabolism , Photoreceptor Cells, Vertebrate/pathology , Retina/drug effects , Retina/metabolism , Retina/pathology , Retinal Degeneration/metabolism , Retinal Degeneration/pathology , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/metabolism , Retinal Pigment Epithelium/pathology
14.
Oncotarget ; 8(20): 33444-33456, 2017 May 16.
Article in English | MEDLINE | ID: mdl-28422719

ABSTRACT

Fbxw7, a subunit of the SCF E3 ubiquitin ligase, recognizes oncoprotein substrates and leads to their proteasomal degradation. Fbxw7 acts as a tumor suppressor via inducing apoptosis and growth arrest in various kinds of tumors. To clarify the initiating role in gastric carcinogenesis as well as the histologic characterization of tumor in Fbxw7 allele haploinsufficient mice, we generated Fbxw7 heterozygous knockout mice (Fbxw7+/-) and treated them with chemical carcinogen N-methyl-N-nitrosourea (MNU) at 5-6 weeks of age. We also treated mouse embryo fibroblasts (MEFs) from Fbxw7+/- and Fbxw7+/+ mice with MNU and examined cell DNA damage via comet assay. The protein expression of Fbxw7 and its substrate c-Myc from mouse tumors, as well as human tumors sampled from six patients, were detected by Western blot. As results, the tumor incidence was obviously higher in Fbxw7+/- mice (13/20) than in Fbxw7+/+ mice (6/20) after 35-week observation. Intestinal metaplasia (P = 0.013) and dysplasia (P = 0.036) were more severe in Fbxw7+/- mice than in Fbxw7+/+ mice. The repair potential of DNA damage was suppressed in MEFs from Fbxw7+/- mice after MNU exposure. Increased c-Myc expression was accompanied by decreased Fbxw7 protein expression in tumor tissues from mouse and patients. In conclusion, Fbxw7 haploinsufficiency increased the risk of gastric carcinogenesis induced by MNU, which is associated with the accumulation of DNA damage as well as c-Myc oncoprotein.


Subject(s)
Cell Transformation, Neoplastic/chemically induced , Cell Transformation, Neoplastic/genetics , DNA Damage , F-Box-WD Repeat-Containing Protein 7/genetics , Haploinsufficiency , Stomach Neoplasms/etiology , Animals , Apoptosis/drug effects , Apoptosis/genetics , Cell Line, Tumor , DNA Repair , Disease Models, Animal , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Gene Expression Regulation, Neoplastic , Gene Knockout Techniques , Gene Order , Gene Targeting , Genes, myc , Genetic Loci , Genetic Predisposition to Disease , Genotype , Methylnitrosourea/adverse effects , Mice , Mice, Knockout , Models, Biological , Stomach Neoplasms/metabolism , Stomach Neoplasms/pathology
15.
Pathol Res Pract ; 213(5): 441-446, 2017 May.
Article in English | MEDLINE | ID: mdl-28285967

ABSTRACT

Chemically-induced mammary tumors in rats by the carcinogens 1-methyl-1-nitrosourea- (MNU) and 7,12-dimethylbenz[a]anthracene (DMBA) are the most widely used models for studies related with human breast cancer. This study aimed to evaluate the immunoexpression of the prognostic factors estrogen receptor α (ERα), progesterone receptor (PR) and Ki-67, in MNU and DMBA-induced rat mammary tumors, in order to know the model that best suits to woman breast cancer. Twenty-eight MNU-induced and 16 DMBA-induced mammary tumors in virgin female Sprague-Dawley rats were analyzed. The expression of the prognostic markers ERα, PR and Ki-67 proliferation index (Ki-67 PI) was assessed by immunohistochemistry. Mitotic activity index (MAI) was also evaluated. More than one histological pattern was identified in each mammary tumor. Carcinomas constituted the lesions most frequently induced by both carcinogens: 33 MNU-induced carcinomas and 23 DMBA-induced carcinomas. All MNU and DMBA-induced mammary carcinomas were ER+/PR+, with a higher expression of ERα when compared with PR. Tumors' weight, the expression of ERα, PR, Ki-67 PI and MAI were higher in MNU-induced mammary carcinomas when compared with the DMBA-induced ones. Statistically significant differences between groups were observed for ERα, PR and MAI (p<0.05). The higher KI-67 PI and MAI in MNU-induced mammary carcinomas are suggestive of a higher aggressiveness of these carcinomas when compared with the DMBA-induced ones, and consequently a worse response to the therapy and a worse prognosis. In this way, the use of the rat model of MNU-induced mammary tumors is advised in experimental protocols aiming to study more aggressive mammary tumors within the group of double-positive mammary tumors (ER+/PR+).


Subject(s)
Breast Neoplasms/metabolism , Carcinoma/metabolism , Estrogen Receptor alpha/metabolism , Ki-67 Antigen/metabolism , Mammary Neoplasms, Experimental/metabolism , Receptors, Progesterone/metabolism , 9,10-Dimethyl-1,2-benzanthracene/adverse effects , Animals , Breast Neoplasms/chemically induced , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Carcinogens , Carcinoma/chemically induced , Carcinoma/diagnosis , Carcinoma/pathology , Disease Models, Animal , Female , Humans , Immunohistochemistry , Mammary Neoplasms, Experimental/chemically induced , Mammary Neoplasms, Experimental/diagnosis , Mammary Neoplasms, Experimental/pathology , Methylnitrosourea/adverse effects , Prognosis , Rats , Rats, Sprague-Dawley
16.
Exp Anim ; 66(3): 191-198, 2017 Aug 05.
Article in English | MEDLINE | ID: mdl-28228618

ABSTRACT

Although non-muscle invasive bladder cancer (NMIBC) is widely seen in men, most laboratory studies of new intravesical therapies to prevent NMIBC have been conducted on female animals. In addition, ozone (O3) has been shown to be a beneficial agent as an intravesical application in the treatment of various disorders. In the current study, we evaluated the immunohistopathological and oxidative-antioxidative effects of intravesical O3 treatment on n-methyl-n-nitrosourea (MNU)-induced NMIBC. Male Wistar-Albino rats (n=51) were divided into four groups: sham (n=6), O3 only (n=15), MNU only (n=15), and MNU+O3 (n=15). The MNU-only and MNU+O3 groups received MNU, and the O3-only group received saline every other week for 10 weeks. The MNU-only group received 1 ml saline in place of O3 treatment, whereas the O3-only and MNU+O3 groups were treated with 1 ml 25 µg/ml O3 between the 7th and 12th weeks. Rat bladders were collected in the 15th week for immunohistopathology and oxidant-antioxidant quantitation. Oxidant-antioxidant parameters were determined by ELISA. Although all surviving rats in the MNU-only group had preneoplastic (4/11, 36.4%) or neoplastic changes (7/11, 63.6%), a completely normal urothelium was observed in 2 rats (2/12, 16.7%) in the MNU+O3-group (P=0.478). More high-grade lesions were observed in the MNU-only group (4/11, 36.4%) than in the MNU+O3 group (1/12, 8.3%) (P=0.120). All oxidant-antioxidant parameters significantly increased (P<0.05) in the O3-only group compared with the sham group. However, only antioxidant superoxide dismutase was remarkably higher (178.9%, P=0.060) in the MNU+O3 group compared with the MNU-only group. This is the first methodologically and pathologically well-described male rat orthotopic bladder carcinogenesis model with intravesical MNU and administration of O3 in NMIBC.


Subject(s)
Methylnitrosourea/adverse effects , Oxidants, Photochemical/administration & dosage , Ozone/administration & dosage , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/prevention & control , Administration, Intravesical , Animals , Antioxidants/metabolism , Disease Models, Animal , Female , Male , Rats, Wistar , Superoxide Dismutase/metabolism , Urinary Bladder Neoplasms/chemically induced , Urinary Bladder Neoplasms/pathology
17.
J Radiat Res ; 58(2): 183-194, 2017 Mar 01.
Article in English | MEDLINE | ID: mdl-27738081

ABSTRACT

The PI3K/AKT pathway is one of the most important signaling networks in human breast cancer, and since it was potentially implicated in our preliminary investigations of radiation-induced rat mammary carcinomas, our aim here was to verify its role. We included mammary carcinomas induced by the chemical carcinogen 1-methyl-1-nitrosourea to determine whether any changes were radiation-specific. Most carcinomas from both groups showed activation of the PI3K/AKT pathway, but phosphorylation of AKT1 was often heterogeneous and only present in a minority of carcinoma cells. The negative pathway regulator Inpp4b was significantly downregulated in both groups, compared with in normal mammary tissue, and radiation-induced carcinomas also showed a significant decrease in Pten expression, while the chemically induced carcinomas showed a decrease in Pik3r1 and Pdk1. Significant upregulation of the positive regulators Erbb2 and Pik3ca was observed only in chemically induced carcinomas. However, no genes showed clear correlations with AKT phosphorylation levels, except in individual carcinomas. Only rare carcinomas showed mutations in PI3K/AKT pathway genes, yet these carcinomas did not exhibit stronger AKT phosphorylation. Thus, while AKT phosphorylation is a common feature of rat mammary carcinomas induced by radiation or a canonical chemical carcinogen, the mutation of key genes in the pathways or permanent changes to gene expression of particular signaling proteins do not explain the pathway activation in the advanced cancers. Although AKT signaling likely facilitates cancer development and growth in rat mammary carcinomas, it is unlikely that permanent disruption of the PI3K/AKT pathway genes is a major causal event in radiation carcinogenesis.


Subject(s)
Gene Expression Regulation, Neoplastic , Mammary Neoplasms, Experimental/genetics , Methylnitrosourea/adverse effects , Nitrosourea Compounds/adverse effects , Phosphatidylinositol 3-Kinases/genetics , Proto-Oncogene Proteins c-akt/genetics , Radiation, Ionizing , Signal Transduction/genetics , Animals , Base Sequence , Female , Gene Expression Regulation, Neoplastic/radiation effects , Immunohistochemistry , Male , Mammary Neoplasms, Experimental/pathology , Mutation, Missense/genetics , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats, Sprague-Dawley , Sequence Deletion/genetics , Signal Transduction/radiation effects
18.
Homeopathy ; 105(3): 265-269, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27473548

ABSTRACT

BACKGROUND: CANOVA(®) (CA) is a homeopathic immunomodulator. It contains several homeopathic medicines prepares according to the Brazilian Pharmacopoeia. CA is indicated in clinical conditions in which the immune system is impaired and against tumors. N-methyl-N-nitrosourea (NMU) is an N-nitroso compound, with genotoxic/mutagenic properties. Although several studies have shown promising results in the use of CA, there are no studies reporting possible antigenotoxic effects. METHOD: This study evaluated the in vitro antigenotoxic and anticytotoxic effects of CA in human lymphocytes exposed to NMU. Samples of human lymphocytes that were subjected to different concentrations of a mixture containing CA and NMU were used. The genotoxicity/antigenotoxicity of CA was evaluated by the comet assay, anticytotoxicity was assessed by quantification of apoptosis and necrosis using acridine orange/ethidium bromide. RESULTS: CA significantly reduced DNA damage induced by NMU and reduced significantly the frequency of NMU-induced apoptosis after 24 h of treatment. CONCLUSION: CA has an important cytoprotective effect significantly reducing the DNA damage and apoptosis induced by the carcinogen NMU.


Subject(s)
Crotalid Venoms/pharmacology , Cytoprotection , DNA Damage/drug effects , Homeopathy , Lymphocytes/drug effects , Plant Extracts/pharmacology , Adult , Apoptosis , Cells, Cultured , Female , Humans , Male , Methylnitrosourea/adverse effects , Mutagenicity Tests
19.
BMC Complement Altern Med ; 16: 260, 2016 Jul 29.
Article in English | MEDLINE | ID: mdl-27473871

ABSTRACT

BACKGROUND: The present study was in quested to study the effects of ß-sitosterol on methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. METHODS: Animals were randomized and divided into four groups of eight animals each. Group I (sham control 1 % CMC in normal saline p.o.); Group II (toxic control, MNU 47 mg/kg, i.v); Group III (MNU 47 mg/kg, i.v + ß-sitosterol, 10 mg/kg, p.o); Group IV (MNU 47 mg/kg, i.v + ß-sitosterol, 20 mg/kg, p.o). Toxicity was induced by single i.v. injection of MNU followed by ß-sitosterol supplementation therapy for 115 days at the dose mentioned above. RESULTS: Treatment with ß-sitosterol evidenced decrease in the alveolar bud and lobule score in the whole mount of the mammary gland. ß-sitosterol exhibited diminishing effect on oxidative stress through synchronizing lipid and enzymatic antioxidant defense. A significant decrease in the saturated and unsaturated fatty acid was evident with the MNU treatment and ß-sitosterol demonstrated a marked effect on it. Pgp 9.5 expression was dose dependently upregulated by ß-sitosterol treatment in comparison to MNU treatment. On the contrary, downregulated NF-kB expression was perceived, when ß-sitosterol was concomitantly administered with MNU. CONCLUSION: ß-sitosterol afforded significant protection against the deleterious effects of MNU.


Subject(s)
Mammary Neoplasms, Experimental/chemically induced , Mammary Neoplasms, Experimental/drug therapy , Methylnitrosourea/adverse effects , Protective Agents/therapeutic use , Animals , Female , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/pathology , Protective Agents/chemistry , Rats , Rats, Wistar
20.
Cell Physiol Biochem ; 38(3): 893-908, 2016.
Article in English | MEDLINE | ID: mdl-26909864

ABSTRACT

BACKGROUND/AIMS: The pathphysiological properties of N-Methyl -N -nitrosourea (MNU) induced photoreceptor degeneration are similar to the hereditary retinitis pigmentosa (RP). The present study sought to explore the beneficial effects of the peonidin, a common aglycone form of anthocyanin, on the MNU induced photoreceptor degeneration via topographic measurements. METHODS: The MNU administrated mouse received peonidin or vehicle injections, and then they were examined by electroretinography (ERG), multi electrode array (MEA), histological and immunohistochemistry studies. RESULTS: The protective effects of peonidin on the MNU administrated retinas were systematically verified and quantified by topographic measures. The peonidin treatment could protect the photoreceptor against the MNU toxicity both functionally and morphologicaly. The most sensitive zone to peonidin therapy was sorted out, indicating that different rescuing kinetics existed between the retinal hemispheres and retinal quadrants. Moreover, the hyperactive spontaneous firing response and the debilitated light induced response in MNU administrated retinas could be partially reversed by peonidin treatment. To our knowledge, this was the first study to explore the pharmacological effects of peonidin on the electrophysiological properties of inner visual signal pathways. CONCLUSION: The peonidin could ameliorate the MNU induced photoreceptors degeneration and rectify the abnormities in the inner visual signal pathways. Future refinements of the knowledge cast insights into the discovery of a novel treatment for human RP.


Subject(s)
Anthocyanins/administration & dosage , Methylnitrosourea/adverse effects , Photoreceptor Cells, Vertebrate/drug effects , Retinal Degeneration/drug therapy , Animals , Anthocyanins/pharmacology , Disease Models, Animal , Electroretinography , Female , Humans , Mice , Photoreceptor Cells, Vertebrate/pathology , Photoreceptor Cells, Vertebrate/physiology , Retinal Degeneration/chemically induced , Retinal Degeneration/pathology , Retinal Degeneration/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL